Results 11 to 20 of about 3,985,609 (307)
Insulin Detemir and Basal Insulin Therapy
With the introduction of insulin detemir (Levemir [Novo Nordisk A/S, Bagsvaerd, Denmark]), a long-acting basal insulin analog, it is an opportune moment to reevaluate the use of basal insulin therapy and consider current treatment strategies, including the use of insulin detemir.
Russell-Jones, DL
openaire +4 more sources
Hypoglycemic coma is considered the most formidable complication of insulin therapy.
Ivana Rabbone +4 more
openaire +2 more sources
New Insulins and Insulin Therapy [PDF]
The introduction of the so-called 'designer' insulins, the insulin analogues, has offered new opportunities in the clinical management of diabetes. Two additional new entities are close to reaching clinical practice. Linjeta™ (formally called VIAject) is not an analogue but rather a different formulation of human insulin which may give it a more rapid ...
Bolinder, Jan +2 more
openaire +7 more sources
The future of insulin therapy [PDF]
Although insulin therapy was already introduced one-hundred years ago, insulin formulations are still being refined to reduce the risk of hypoglycaemia and of other insulin side effects such as weight gain. This review summarises the available clinical data for some ongoing developments of new insulins and evaluates their potential for future insulin ...
openaire +2 more sources
New Insulins, Biosimilars, and Insulin Therapy [PDF]
Exogenous insulin has greatly changed the outlook for patients with diabetes ever since its discovery and isolation. Yet, serious complications can result as patients experience both hyperglycemic and hypoglycemic states, even when they strictly follow an insulin regimen. Several chemically or genetically modified insulins have been developed that tune
Thomas, Danne +2 more
openaire +11 more sources
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience [PDF]
Basal insulin therapy can improve glycemic control in people with type 2 diabetes. However, timely initiation, optimal titration, and proper adherence to prescribed basal insulin regimens are necessary to achieve optimal glycemic control.
Sony Wibisono Mudjanarko +10 more
core +2 more sources
Management and efficacy of intensified insulin therapy starting in outpatients [PDF]
Diabetic patients under multiple injection insulin therapy (i.e., intensified insulin therapy, IIT) usually start this treatment during hospitalization. We report here on the logistics, efficacy, and safety of IIT, started in outpatients.
Winkelmann, W. +11 more
core +1 more source
Blood Glucose Meter Buying Behavior of Diabetic Patients: Factors Influencing Purchase
ObjectiveTo understand the blood glucose meter buying behavior of type 2 diabetic patients with poor glycemic control (two or more HbA1c ≥ 8% during visits in one year) and identify factors influencing it.MethodsA survey was conducted among 585 diabetic ...
Bai-ling Pan +3 more
doaj +1 more source
Adherence to Insulin Therapy [PDF]
IN BRIEF Six million people with diabetes use insulin either alone or in combination with an oral medication. Many barriers exist that lead to poor adherence with insulin. However, there is an underwhelming amount of data on interventions to address these barriers and improve insulin adherence.
Sarbacker, G. Blair +1 more
openaire +2 more sources
Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran
Insulin has been considered as a therapy option of last resort in type 2 diabetes (T2DM) management. Delay in insulin therapy is common in these patients.
Zahra Mostafavian +4 more
doaj +1 more source

